Generics 37

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Sparfloxacin manufacturers

37 products found

Filters

37 products found

sparfloxacin

Tablets, film coated 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, India
Registered in
India
Available for
Licensing with supply, Distribution only
MAs for sale
India
Manufacturer #22627

Manufacturer usually replies in 4 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, TGA
Manufacturer #18120

Manufacturer usually replies in 7 days

sparfloxacin

Tablets 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
WHO
Manufacturer #20897

Manufacturer usually replies in 5 days

sparfloxacin

Tablets 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20848

Manufacturer usually replies in 3 days

sparfloxacin

Tablets 200 mg, 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722

Manufacturer usually replies in 3 days

sparfloxacin

Tablets 200 mg, 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 7 days

sparfloxacin

Tablets 100 mg, 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20275

Manufacturer usually replies in 10 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20290

Manufacturer usually replies in 8 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20259

Manufacturer usually replies in 9 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20267

Manufacturer usually replies in 9 days

sparfloxacin

Tablets 200 mg, 400 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19670

Manufacturer usually replies in 8 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21124

Manufacturer usually replies in 12 days

sparfloxacin

Tablets 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19729

Manufacturer usually replies in 12 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20499

Manufacturer usually replies in 75 days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21499

Manufacturer usually replies in nan days

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20858

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20241

sparfloxacin

Tablets 200 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19837

Want to view all 37 products? Create your free account today!

SPARFLOXACIN

Sparfloxacin is a fluoroquinolone antibiotic. It is used in the treatment of bacterial infections, specifically community-acquired lower respiratory tract infections like acute sinusitis, exacerbations of chronic bronchitis caused by susceptible bacteria, and community-acquired pneumonia. it is active against Chlamydia pneumonia, Haemophilus parainfluenzae, Haemophilus influenza, Moraxella catarrhalis, Streptococcus pneumonia, Mycoplasma pneumonia, Enterobacter cloacae, Klebsiella pneumonia, and Staphylococcus aureus. However, it has been withdrawn from sales in the USA. Sparfloxacin is sold under the brand names Zagam, Zagam Respipac among others. Rhone DPC Europe patented Sparfloxacin in 1985 and approved it for medical use in 1993. However, it is no longer available in the United States due to a controversial safety profile.

Dosage and Administration

Sparfloxacin is sold as 200mg tablets in a blister pack of 11 or a bottle of 55 tablets. It is taken orally with or without food, however, the patient has to take antacids containing magnesium and aluminum or sucralfate or Videx, or the pediatric powder for oral solution, 4 hours after taking Sparfloxacin. For patients with normal renal function, the recommended daily dose is, two 200- mg tablets, as the loading dose on day one, followed by one 200-mg tablet, every 24 hours, for a total of 10 days of therapy. For patients with renal impairment whose creatinine clearance is lower than 50 mL per minute, the loading dose is two 200-mg tablets on day 1, followed by one 200-mg tablet, every 48 hours, for a total of 9 days of therapy.

The PRICE of Sparfloxacin

In India, the price of the generic version of the 200 mg tablets cost USD 13.06. however, there are several drug manufacturers of Sparfloxacin, and is available at much lower prices too. It is not approved for sale in the USA anymore.

How does it work?

Sparfloxacin is quinolones and fluoroquinolones. Its main action is bactericidal, which is actively killing bacteria. It works by inhibiting the bacterial DNA gyrase or the topoisomerase IV enzyme. This in turn inhibits DNA replication and transcription. It easily enters the cells, thus is often used to treat intracellular pathogens such as Legionella pneumophila and Mycoplasma pneumonia. DNA gyrase is the main target for many gram-negative bacteria, whereas topoisomerase IV is the target for many gram-positive bacteria.

Finding Sparfloxacin Manufacturers and Suppliers:

The process of finding trusted Sparfloxacin manufacturers and Sparfloxacin suppliers can be made quicker and more accessible by using Pipelinepharma's online platform, a B2B the marketplace that lets you finalize the deals of pharmaceutical products in a matter of a few clicks. In addition, it is easy to use an online platform to grow your business opportunities. The robust search engine makes it convenient to search for manufacturers and suppliers of Sparfloxacin. The search can be further refined with industry-specific filters such as dossier type, country of origin, GMP approvals, and search criteria for Wholesaler, etc. helping to get in contact with the preferred manufacturer and supplier readily.